Michael Bell Brian's most recent trade in Guardant Health Inc was a trade of 2,084 Common Stock done . Disclosure was reported to the exchange on July 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 2,084 | 44,085 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 2,084 | 10,421 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.71 per share. | 01 Jul 2025 | 1,057 | 43,028 (0%) | 0% | 50.7 | 53,600 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2025 | 2,039 | 8,156 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2025 | 2,039 | 43,660 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.29 per share. | 15 Jun 2025 | 1,659 | 42,001 (0%) | 0% | 49.3 | 81,772 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2025 | 1,233 | 41,621 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2025 | 1,233 | 3,699 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 2,084 | 12,505 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 2,084 | 41,445 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.47 per share. | 01 Apr 2025 | 1,057 | 40,388 (0%) | 0% | 42.5 | 44,891 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 2,039 | 10,195 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 2,039 | 41,020 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.89 per share. | 15 Mar 2025 | 1,659 | 39,361 (0%) | 0% | 42.9 | 71,155 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 1,233 | 38,981 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 1,233 | 4,932 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 33,498 | 33,498 | - | - | Stock Option (Right to Buy) | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 22,332 | 22,332 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 7,108 | 14,220 | - | - | Performance-Based Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 7,108 | 40,285 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.55 per share. | 01 Mar 2025 | 2,537 | 37,748 (0%) | 0% | 42.5 | 107,949 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 6,617 | 35,538 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 6,617 | 0 | - | - | Performance-Based Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.98 per share. | 01 Feb 2025 | 2,361 | 33,177 (0%) | 0% | 47.0 | 110,920 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 3,309 | 30,226 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 3,309 | 0 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.50 per share. | 15 Jan 2025 | 1,305 | 28,921 (0%) | 0% | 37.5 | 48,938 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 2,084 | 27,772 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 2,084 | 14,589 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.55 per share. | 01 Jan 2025 | 855 | 26,917 (0%) | 0% | 30.5 | 26,120 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 2,039 | 12,234 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 2,039 | 27,347 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.76 per share. | 15 Dec 2024 | 1,659 | 25,688 (0%) | 0% | 34.8 | 57,667 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 1,233 | 25,308 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 1,233 | 6,165 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2024 | 59,534 | 59,534 | - | - | Stock Option (Right to Buy) | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2024 | 39,689 | 39,689 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2024 | 8,211 | 28,237 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2024 | 8,211 | 16,673 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.12 per share. | 01 Oct 2024 | 4,162 | 24,075 (0%) | 0% | 22.1 | 92,063 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2024 | 2,039 | 21,685 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2024 | 2,039 | 14,273 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.79 per share. | 15 Sep 2024 | 1,659 | 20,026 (0%) | 0% | 26.8 | 44,445 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2024 | 1,233 | 7,398 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2024 | 1,233 | 19,646 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 8,034 | 16,312 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 8,034 | 21,720 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.21 per share. | 15 Jun 2024 | 3,307 | 18,413 (0%) | 0% | 30.2 | 99,904 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 1,233 | 13,686 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 1,233 | 8,631 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 1,233 | 9,864 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 1,233 | 12,882 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.74 per share. | 15 Mar 2024 | 429 | 12,453 (0%) | 0% | 17.7 | 7,610 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2024 | 3,308 | 3,309 | - | - | RESTRICTED STOCK UNITS | |
| Guardant Health Inc | Brian Michael Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2024 | 3,308 | 13,005 (0%) | 0% | 0 | COMMON STOCK | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.20 per share. | 15 Jan 2024 | 1,356 | 11,649 (0%) | 0% | 24.2 | 32,815 | COMMON STOCK |
| Guardant Health Inc | Brian Bell Michael | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 1,233 | 11,097 | - | - | RESTRICTED STOCK UNITS | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 1,233 | 10,124 (0%) | 0% | 0 | COMMON STOCK | |
| Guardant Health Inc | Brian Michael Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.19 per share. | 15 Dec 2023 | 427 | 9,697 (0%) | 0% | 28.2 | 12,037 | COMMON STOCK |
| Guardant Health Inc | Brian Bell Michael | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 37,326 | 37,326 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Guardant Health Inc | Michael Bell Brian | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 24,884 | 24,884 | - | - | RESTRICTED STOCK UNITS | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2023 | 1,233 | 13,563 | - | - | RESTRICTED STOCK UNITS | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2023 | 1,233 | 8,512 (0%) | 0% | 0 | COMMON STOCK | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.86 per share. | 15 Jun 2023 | 427 | 8,085 (0%) | 0% | 37.9 | 16,166 | COMMON STOCK |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 36,519 | 36,519 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 24,346 | 24,346 | - | - | RESTRICTED STOCK UNITS | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2023 | 4,931 | 14,796 | - | - | RESTRICTED STOCK UNITS | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2023 | 4,931 | 8,982 (0%) | 0% | 0 | COMMON STOCK | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.78 per share. | 15 Mar 2023 | 1,703 | 7,279 (0%) | 0% | 26.8 | 45,606 | COMMON STOCK |
| Guardant Health Inc | Michael Brian Bell | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2023 | 3,309 | 5,371 (0%) | 0% | 0 | COMMON STOCK | |
| Guardant Health Inc | Michael Brian Bell | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2023 | 3,309 | 6,617 | - | - | RESTRICTED STOCK UNITS | |
| Guardant Health Inc | Michael Brian Bell | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.43 per share. | 15 Jan 2023 | 1,320 | 4,051 (0%) | 0% | 30.4 | 40,168 | COMMON STOCK |
| Guardant Health Inc | Michael Brian Bell | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2022 | 39,454 | 39,454 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Guardant Health Inc | Michael Brian Bell | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2022 | 19,727 | 19,727 | - | - | RESTRICTED STOCK UNITS | |
| Guardant Health Inc | Michael Brian Bell | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2022 | 3,308 | 9,926 | - | - | RESTRICTED STOCK UNITS | |
| Guardant Health Inc | Michael Brian Bell | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2022 | 3,308 | 3,308 (0%) | 0% | 0 | COMMON STOCK | |
| Guardant Health Inc | Michael Brian Bell | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.58 per share. | 15 Jan 2022 | 1,246 | 2,062 (0%) | 0% | 77.6 | 96,665 | COMMON STOCK |
| Guardant Health Inc | Michael Brian Bell | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2021 | 26,467 | 26,467 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Guardant Health Inc | Michael Brian Bell | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2021 | 13,234 | 13,234 | - | - | RESTRICTED STOCK UNITS | |
| Caredx Inc | Michael Brian Bell | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 48.15 per share. | 03 Nov 2020 | 32,574 | 103,343 (0%) | 0% | 48.2 | 1,568,487 | Common Stock |
| Caredx Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2020 | 12,667 | 19,333 | - | - | Employee Stock Option (right to buy) | |
| Caredx Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.17 per share. | 03 Nov 2020 | 12,667 | 126,277 (0%) | 0% | 27.2 | 344,162 | Common Stock |
| Caredx Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2020 | 4,167 | 21,875 | - | - | Employee Stock Option (right to buy) | |
| Caredx Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.24 per share. | 03 Nov 2020 | 4,167 | 131,612 (0%) | 0% | 12.2 | 51,004 | Common Stock |
| Caredx Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2020 | 3,750 | 13,125 | - | - | Employee Stock Option (right to buy) | |
| Caredx Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.90 per share. | 03 Nov 2020 | 3,750 | 135,362 (0%) | 0% | 5.9 | 22,125 | Common Stock |
| Caredx Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.00 per share. | 03 Nov 2020 | 3,333 | 113,610 (0%) | 0% | 1 | 3,333 | Common Stock |
| Caredx Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2020 | 3,333 | 6,667 | - | - | Employee Stock Option (right to buy) | |
| Caredx Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2020 | 1,168 | 4,963 | - | - | Employee Stock Option (right to buy) | |
| Caredx Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.31 per share. | 03 Nov 2020 | 1,168 | 127,445 (0%) | 0% | 6.3 | 7,370 | Common Stock |
| Caredx Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2020 | 555 | 1,667 | - | - | Employee Stock Option (right to buy) | |
| Caredx Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.80 per share. | 03 Nov 2020 | 555 | 135,917 (0%) | 0% | 2.8 | 1,554 | Common Stock |
| Caredx Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.65 per share. | 06 Aug 2020 | 619 | 110,277 (0%) | 0% | 34.6 | 21,448 | Common Stock |